Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Plos Neglected Tropical Diseases|April 3, 2018
Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotypingFernanda Cristina Costa, Amanda Fortes Francisco, Shiromani Jayawardhana, et al.
Plos Genetics|December 16, 2020
Culture-free genome-wide locus sequence typing (GLST) provides new perspectives on Trypanosoma cruzi dispersal and infection complexityPhilipp Schwabl, Jalil Maiguashca Sánchez, Jaime A Costales, et al.
BMC Genomics|October 6, 2012
Comparative genomic analysis of human infective Trypanosoma cruzi lineages with the bat-restricted subspecies T. cruzi marinkelleiOscar Franzén, Carlos Talavera-López, Stephen Ochaya, et al.
Bulletin of the World Health Organization|May 9, 2007
The importance of militaries from developing countries in global infectious disease surveillanceJean-Paul Chretien, David L Blazes, Rodney L Coldren, et al.
World Hospitals and Health Services : the Official Journal of the International Hospital Federation|April 15, 2008
The importance of militaries from developing countries in global infectious disease surveillanceJean-Paul Chretien, David L Blazes, Rodney L Coldren, et al.
Cancer Chemotherapy and Pharmacology|September 13, 2015
Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trialRobert J Morgan, Timothy W Synold, Jeffrey A Longmate, et al.
Scientific Reports|October 18, 2016
Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stageAmanda Fortes Francisco, Shiromani Jayawardhana, Michael D Lewis, et al.
Plos Neglected Tropical Diseases|May 13, 2025
Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas diseaseFrauke Assmus, Ayorinde Adehin, Richard M Hoglund, et al.
Plos Neglected Tropical Diseases|April 18, 2020
Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protectionGurdip Singh Mann, Amanda F Francisco, Shiromani Jayawardhana, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 3, 2012
Candidate targets for Multilocus Sequence Typing of Trypanosoma cruzi: validation using parasite stocks from the Chaco Region and a set of reference strainsJuan J Lauthier, Nicolás Tomasini, Christian Barnabé, et al.
Pageof 8